Evidence map›Paper›PMID 34118894›Full record

ArticleBMC infectious diseases2021

Clinical, laboratory, and chest CT features of severe versus non-severe pediatric patients with COVID-19 infection among different age groups.

Meisam Hoseinyazdi, Saeid Esmaeilian, Reza Jahankhah, Arash Teimouri, Farzaneh Ghazi Sherbaf, Faranak Rafiee, Reza Jalli, Sedighe Hooshmandi

Abstract readComparative Study
In one paragraph

Article in BMC infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Iranian Pediatric COVID-19 Epidemiology and Clinical Characteristics.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Meisam HoseinyazdiMedical Imaging research center, Shiraz University of Medical Sciences, Shiraz, Iran.
Saeid EsmaeilianMedical Imaging research center, Shiraz University of Medical Sciences, Shiraz, Iran.
Reza JahankhahMedical Imaging research center, Shiraz University of Medical Sciences, Shiraz, Iran.
Arash TeimouriMedical Imaging research center, Shiraz University of Medical Sciences, Shiraz, Iran. arashteimourirad@gmail.com.ORCID http://orcid.org/0000-0001-8018-5989
Farzaneh Ghazi SherbafMedical Imaging research center, Shiraz University of Medical Sciences, Shiraz, Iran.
Faranak RafieeMedical Imaging research center, Shiraz University of Medical Sciences, Shiraz, Iran.
Reza JalliMedical Imaging research center, Shiraz University of Medical Sciences, Shiraz, Iran.
Sedighe HooshmandiMedical Imaging research center, Shiraz University of Medical Sciences, Shiraz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study was performed with the intention of comparing the clinical, laboratory, and chest computed tomography (CT) findings between severe and non-severe patients as well as between different age groups composed of pediatric patients with confirmed COVID-19.

methodThis study was carried out on a total of 53 confirmed COVID-19 pediatric patients who were hospitalized in Namazi and Ali Asghar Hospitals, Shiraz, Iran. The patients were divided into two severe (n = 27) and non-severe (n = 28) groups as well as into other three groups in terms of their age: aged less than two years, aged 3-12 years and 13-17 years. It should be noted that CT scans, laboratory, and clinical features were taken from all patients at the admission time. Abnormal chest CT in COVID-19 pneumonia was found to show one of the following findings: ground-glass opacities (GGO), bilateral involvement, peripheral and diffuse distribution.

resultFever (79.2%) and dry cough (75.5%) were the most common clinical symptoms. Severe COVID-19 patients showed lymphocytosis, while the non-severe ones did not (P = 0.03). C-reactive protein (CRP) was shown to be significantly lower in patients aged less than two years than those aged 3-12 and 13-17 years (P = 0.01). It was shown also that O

conclusionLymphocytosis and abnormal CT findings are among the factors most associated with COVID-19 severity. It was, moreover, showed that the severity of COVID-19, O

Indexed as

COVID-19AdolescentChildChild, PreschoolHumansInfantInfant, NewbornLungTomography, X-Ray ComputedChildrenClinical symptomsCOVID-19CTLaboratory findingsPediatricsSARS-CoV-2

Identifiers

PMID34118894
PMCPMC8196295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.